Table 1.
|
Patient |
Healthy volunteers |
|
---|---|---|---|
(n = 28) | (n = 28) | ||
Age (years) |
|
|
|
Median |
63 ± 11 |
64 ± 12 |
|
Minimum |
30 |
30 |
|
Maximum |
77 |
79 |
|
Histological Grade |
|
|
|
Moderately differentiated |
11 |
|
|
Poorly differentiated |
11 |
|
|
Well-differentiated |
1 |
|
|
Unknown |
5 |
|
|
Site |
|
|
|
Tubal |
3 |
|
|
Peritoneal |
4 |
|
|
Ovary |
20 |
|
|
Endometrial |
1 |
|
|
FIGO Stage |
|
|
|
4 |
6 |
|
|
4B |
1 |
|
|
3C |
17 |
|
|
3B |
3 |
|
|
2C |
1 |
|
|
CA-125 Result |
|
|
|
Yes |
19 |
|
|
No |
9 |
|
|
BRCA1/2 mutation |
|
|
|
Yes |
3 |
|
|
Unknown |
24 |
|
|
No |
1 |
|
|
Post Menopausal |
|
|
|
Yes |
23 |
|
|
No |
2 |
|
|
Unknown |
2 |
|
|
Pre-operative Chemotherapy |
|
|
|
Yes |
9 |
|
|
No |
19 |
|
|
Prior cancer |
|
|
|
Yes |
2 (breast, Craniopharyngioma) |
||
No |
26 |
|
|
Tumour Size |
|
|
|
mean |
59.3 ± 33.6 |
|
|
min |
20 |
|
|
max |
140 |
|
|
Degree of cytoreduction |
|
|
|
< 2 cm |
8 |
|
|
> 2 cm |
8 |
|
|
No Macroscopic |
13 |
|
|
Unknown |
1 |
|
|
Survival Statistics |
|
|
|
Dead of disease |
12 |
|
|
Recurred |
12 |
|
|
No evidence of disease | 4 |